146 related articles for article (PubMed ID: 24527800)
1. miR-296/Scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo.
Savi F; Forno I; Faversani A; Luciani A; Caldiera S; Gatti S; Foa P; Ricca D; Bulfamante G; Vaira V; Bosari S
Clin Sci (Lond); 2014 Aug; 127(4):233-42. PubMed ID: 24527800
[TBL] [Abstract][Full Text] [Related]
2. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
3. miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer.
Hui Z; Yiling C; Wenting Y; XuQun H; ChuanYi Z; Hui L
FEBS Lett; 2015 Mar; 589(7):812-21. PubMed ID: 25725194
[TBL] [Abstract][Full Text] [Related]
4. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
[TBL] [Abstract][Full Text] [Related]
5. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.
Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH
Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
7. MiR-199b-5p targets HER2 in breast cancer cells.
Fang C; Zhao Y; Guo B
J Cell Biochem; 2013 Jul; 114(7):1457-63. PubMed ID: 23296799
[TBL] [Abstract][Full Text] [Related]
8. GSE1 negative regulation by miR-489-5p promotes breast cancer cell proliferation and invasion.
Chai P; Tian J; Zhao D; Zhang H; Cui J; Ding K; Liu B
Biochem Biophys Res Commun; 2016 Feb; 471(1):123-8. PubMed ID: 26828271
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
[TBL] [Abstract][Full Text] [Related]
10. miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2.
Zhang Y; Xu G; Liu G; Ye Y; Zhang C; Fan C; Wang H; Cai H; Xiao R; Huang Z; Luo Q
Biochem Biophys Res Commun; 2016 Aug; 476(4):607-613. PubMed ID: 27264952
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
12. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
[TBL] [Abstract][Full Text] [Related]
13. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA.
Hossain A; Kuo MT; Saunders GF
Mol Cell Biol; 2006 Nov; 26(21):8191-201. PubMed ID: 16940181
[TBL] [Abstract][Full Text] [Related]
14. Involvement of IGF-1R regulation by miR-515-5p modifies breast cancer risk among BRCA1 carriers.
Gilam A; Edry L; Mamluk-Morag E; Bar-Ilan D; Avivi C; Golan D; Laitman Y; Barshack I; Friedman E; Shomron N
Breast Cancer Res Treat; 2013 Apr; 138(3):753-60. PubMed ID: 23549953
[TBL] [Abstract][Full Text] [Related]
15. MiR-185 is involved in human breast carcinogenesis by targeting Vegfa.
Wang R; Tian S; Wang HB; Chu DP; Cao JL; Xia HF; Ma X
FEBS Lett; 2014 Nov; 588(23):4438-47. PubMed ID: 25448984
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab.
Nishida N; Mimori K; Fabbri M; Yokobori T; Sudo T; Tanaka F; Shibata K; Ishii H; Doki Y; Mori M
Clin Cancer Res; 2011 May; 17(9):2725-33. PubMed ID: 21220473
[TBL] [Abstract][Full Text] [Related]
17. MiR-125a-5p functions as a tumour suppressor in breast cancer by downregulating BAP1.
Yan L; Yu MC; Gao GL; Liang HW; Zhou XY; Zhu ZT; Zhang CY; Wang YB; Chen X
J Cell Biochem; 2018 Nov; 119(11):8773-8783. PubMed ID: 30076753
[TBL] [Abstract][Full Text] [Related]
18. Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.
Ma F; Zhang J; Zhong L; Wang L; Liu Y; Wang Y; Peng L; Guo B
Gene; 2014 Feb; 535(2):191-7. PubMed ID: 24315818
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-186-5p overexpression modulates colon cancer growth by repressing the expression of the FAM134B tumour inhibitor.
Islam F; Gopalan V; Vider J; Wahab R; Ebrahimi F; Lu CT; Kasem K; Lam AKY
Exp Cell Res; 2017 Aug; 357(2):260-270. PubMed ID: 28549913
[TBL] [Abstract][Full Text] [Related]
20. MiRNA-183-5p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting the PDCD4.
Cheng Y; Xiang G; Meng Y; Dong R
Reprod Biol; 2016 Sep; 16(3):225-233. PubMed ID: 27476679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
